Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
Go back to Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial| (NASDAQ: MNPR) | Delayed: 83.72 -1.52 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.24 | 52 Week High | $ | |||
| Open | $85.24 | 52 Week Low | $ | |||
| Day High | $86.69 | P/E | N/A | |||
| Day Low | $82.92 | EPS | $ | |||
| Volume | 268,172 | |||||
